Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction

International Journal of Impotence Research

Volumn 16, Issue 2, 2004, Pages 121-129

  Guay, A ^a   Jacobson, J ^a   Munarriz, R ^b   Traish, A ^b   Talakoub, L ^b   Quirk, F ^c   Goldstein, I ^d   Spark, R ^d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adrenal androgens; DHEA; Female androgen deficiency; Female sexual dysfunction; Premenopause; Testosterone

Indexed keywords

ANDROGEN; CORTICOTROPIN; HYDROCORTISONE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; AROUSAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL REGULATION; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; LIBIDO DISORDER; OVARY; PREMENOPAUSE; PRIORITY JOURNAL;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGE FACTORS; ANDROGENS; ANDROSTENEDIONE; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LIBIDO; MIDDLE AGED; OVARY; PREGNENOLONE; PREMENOPAUSE; PROGESTERONE; QUESTIONNAIRES; REFERENCE VALUES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 2342484527     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901176     Document Type: Article

References (25)

1. Basson R et al. Report of an international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888-893.
2. Rosen RC, Taylor JF, Leiblum SR, Bachman GA. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecology clinic. J Sex Marital Ther 1993; 19: 171-188.
3. Laumann EO, Paik AP, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc 1999; 281: 537-544.
4. Brauanstein G et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fert Ster 2002; 77: 660-665.
5. Labrie F et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-2402.
6. Guay AT et al. Androgens in healthy premenopausal women with and without sexual dysfunction: A. Androgen levels in women aged 20 to 49 years with no complaints of sexual dysfunction. Int J Imp Res, in press.
7. Quirk FH et al. Development of sexual function questionnaire for clinical trials of female sexual dysfunction. J Women Health Gender-based Med 2002; 11: 277-289.
8. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976; 42: 247-253.
9. Vierhapper H, Nowotny P, Waldhausl W. Determination of testosterone production rates in men and women using stable isotope/dilution and mass spectrometry. J Clin Endocrinol Metab 1997; 82: 1492-1496.
10. Massafra C et al. Androgens and osteocalcin during the menstrual cycle. J Clin Endocrinol Metab 1999; 84: 971-974.
11. Miller KK et al. Androgen deficiency in women with hypopiytuitarism. J Clin Endocrinol Metab 2001; 86: 561-567.
12. Mushayandebvu T et al. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fert Ster 1996; 65: 721-723.
13. Maccario M et al. Relationships between dehydroepiandrosterone-sulfate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin Endocrinol 1999; 50: 595-600.
14. Sulcova J, Hill M, Hampl R, Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulfate in normal subjects. J Endocrinol 1997; 154: 57-62.
15. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551-555.
16. Lasley BL et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002; 87: 3760-3767.
17. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80: 1429-1430.
18. Palmert MR et al. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001; 86: 4536-4542.
19. Riepe FG, Mahler P, Sippel WG, Partsch CJ. Longitudinal study of plasma pregnenolone and 17-hydroxypregnenolone in full-term and preterm neonates at birth and during the early neonatal period. J Clin Endocrinol Metab 2002; 87: 4301-4306.
20. Arvat E et al. Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose response study. J Clin Endocrinol Metab 2000; 85: 3141-3146.
21. Goldstat R et al. Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women. Menopause 2003; 10: 390-398.
22. Bancroft J, Loftus J, Long JS. Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav 2003; 32: 193-208.
23. Rosen RC, Laumann EO. The prevalence of sexual problems in women: how valid are comparisons across studies? Commentary on Bancroft, Loftus, and Long's (2003) 'Distress about sex: a National Survey of women in heterosexual relationships'. Arch Sex Behav 2003; 32: 209-211.
24. Posten HO. Small sample power of the Wilcoxon test over the Pearson system, and comparison with the t-test. J Stat Comput Simulat 1983; 16: 1-18.
25. Posten HO. Robustness of the two-sample t-test under violations of the assumption of homogeneity assumption Part II. J Comput Simul 1992; 8: 2169-2184.